ofri telem (ucb) more exact results in gauge theories: confine & chsym break @harvard cmsa 9/10/2021
Published Streamed 3 years ago • 276 plays • Length 1:37:43Download video MP4
Download video MP3
Similar videos
-
1:25:56
hitoshi murayama (ucb/ipmu) exact results in qcd & chiral gauge theories @harvard cmsa 8/25/2021
-
1:37:38
yizhi you (princeton) fracton criticality & topological transition beyond rg @harvard cmsa 6/09/2021
-
2:48:53
mikhail shifman (umn) what can supersymmetry do that other qft cannot @harvard cmsa 6/17/2021
-
1:44:16
silviu pufu (princeton) exact symmetries & threshold states in 2d qcd models @harvard cmsa 3/17/2021
-
1:19:24
beni yoshida (perimeter) on the firewall puzzle @harvard cmsa 8/12/2021
-
53:51
david bruce: keepers of wisdom - profiles in uncommon courage
-
8:14
m-theory, string theory and supersymmetry
-
1:15:38
«innovations in trifocal iol technology the finevision family» by dr robert ang
-
0:59
charles j. de mesa, d.o.
-
1:48
meet dr. julius huebner, md | orthopedic surgery | meet dr. right
-
2:35
quizartinib for frontline flt3-itd aml: updated results from the quantum-first trial
-
1:56:26
satoshi yamaguchi (osaka u) susy qft in 3 1d and fermionic fracton phases @harvard cmsa 3/10/2021
-
1:56
the efficacy of olutasidenib in patients with r/r idh-mutant aml
-
1:39:17
william witczak-krempa (u montreal) corner fluctuations and entanglement @harvard cmsa 9/08/2021
-
0:17
physiol toric calculator: accuracy matters
-
1:42:20
mohamed anber (durham) global structure of standard model: nonpert processes @harvard cmsa 2/10/2022
-
2:14
rationale & results of a pilot study of elotuzumab in myelofibrosis
-
3:42
further analysis of quantum-first: the impact of allo-hct combined with quizartinib in flt3-itd aml
-
1:07
#tomorrowsdiscoveries: health care in america – david bruce hellmann, m.d.
-
3:19:30
yoshio kikukawa (u tokyo) gauge-invariant overlap weyl fermions 16 of so(10) @harvard cmsa 5/21/2020
-
1:45:06
louis taillefer-new signatures of pseudogap phase of cuprate superconductors@harvard cmsa 10/15/2020
-
1:59
tangible benefit for flt3-itd r/r aml on quizartinib